PRLR and neoplasm: Disease-free survival after 5 years was documented in 36 out of 81 (44%) patients with tumours with high PRLR expression and 7 out of 8 (87%) patients with tumours showing low PRLR expression (P=0.017, log-rank test, Figure 4B).